High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers
- 1 February 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 58 (11) , 945-952
- https://doi.org/10.1016/0024-3205(96)00037-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changesBiomedicine & Pharmacotherapy, 1995
- Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medicationLife Sciences, 1995
- Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this differenceLife Sciences, 1994
- Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidenceLife Sciences, 1993
- Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseasesMedicinal Research Reviews, 1992
- (-)Deprenyl-Medication: A Strategy To Modulate the Age-Related Decline of the Striatal Dopaminergic SystemJournal of the American Geriatrics Society, 1992
- Maintenance on l-deprenyl prolongs life in aged male ratsLife Sciences, 1990
- Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-) deprenylLife Sciences, 1989
- The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenylMechanisms of Ageing and Development, 1988
- Effects of nicotine on avoidance conditioning of inbred strains of micePsychopharmacology, 1966